What GLP-1 Weight Loss Clinics in Austin Actually Charge
From Dell Seton's metabolic program to Domain med spa Instagram ads, a reported guide to the real costs, real risks, and right questions to ask before you spend a dollar.
From Dell Seton’s metabolic program to Domain med spa Instagram ads, a reported guide to the real costs, real risks, and right questions to ask before you spend a dollar.
The Austin GLP-1 Market, Plainly Described
Austin has a bifurcated healthcare geography that makes this conversation harder than it needs to be. If you live west of MoPac or north of 183, you’re probably within a few miles of multiple boutique med spas and functional medicine clinics that have pivoted heavily into GLP-1 prescribing over the past two years. East Austin and Del Valle tell a different story — federally qualified health centers, primary care practices, and insurance prior authorization hurdles that make GLP-1 prescribing genuinely complicated.
That geographic split matters. The patients most likely to benefit clinically from GLP-1 medications — people with obesity-related comorbidities like Type 2 diabetes, hypertension, and sleep apnea — are disproportionately on the east side of that divide. The people most likely to encounter a frictionless prescription pipeline with no labs, no wait, and no questions? West side. I don’t think Austin has fully reckoned with how uncomfortable that is.
Type “GLP-1 clinic Austin” into a search engine and you’ll get paid advertisements, then more paid advertisements, then national telehealth platforms wearing local landing pages like masks. Almost no journalism. No consumer guide names actual providers, reports actual prices, and gives readers the clinical vocabulary to distinguish responsible practice from a web form with a PayPal button. This piece tries to be that resource.
Semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) are serious medications — not the medical equivalent of a B12 shot. Personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, or pancreatitis creates genuine prescribing risks. Dosing errors during titration cause significant GI distress and, in serious cases, worse. The difference between a good clinic and a bad one is whether anyone reviewed your history before writing the prescription. That’s it. That’s the whole thing.
What the Out-of-Pocket Cost Actually Looks Like, By Provider Type
Prices in this market shift frequently. Verify every figure before making a decision.
For patients with qualifying commercial insurance, Novo Nordisk’s WeGoTogether savings card brings the monthly out-of-pocket cost to as low as $0–$25 for branded Wegovy, with the card covering up to $500 of the remainder. Prior authorization is almost always required. Your physician must document a BMI of 30 or higher, or 27 or higher with a qualifying comorbidity.
Without insurance or savings card eligibility, branded Wegovy retails at roughly $1,300 to $1,500 per month depending on dose. That’s a genuine barrier for anyone whose employer plan excludes weight-loss medications — which describes a substantial portion of the Austin workforce.
Compounded semaglutide is where pricing varies most dramatically. Clinics contacted during reporting quoted monthly medication costs of approximately $200 to $400 — not including program evaluation or follow-up fees. Clinics along South Congress and in the Domain have posted prices in this range online, with variation based on whether injections are administered in-office or self-administered at home. Some require a multi-month package commitment upfront. Press on that before you hand over a credit card. Compounded tirzepatide runs higher — generally $300 to $500 per month at comparable Austin operations — reflecting higher drug input costs.
National telehealth subscriptions sit at a different price point. Ro Body, Found, and Hims & Hers each have Austin-resident users; published pricing runs $99 to $299 per month. These services connect Austin patients with a licensed Texas prescriber via video, which satisfies state telehealth requirements, but they don’t provide local lab coordination, in-person examination, or continuity with a physician who knows your chart. More on that later.
At UT Health Austin’s Metabolic Weight Management program at Dell Seton Medical Center, new patient evaluations bill through insurance at standard specialist rates. Self-pay patients get quotes through UT Health Austin’s financial counseling office. The evaluation includes labs — actual clinical work, not an afterthought. Independent obesity medicine physicians in Austin generally charge $200 to $500 for a self-pay new patient evaluation.
One distinction worth keeping clear: drug cost and program cost are not the same thing. A clinic advertising “$200/month semaglutide” may charge separately for the initial visit, lab review, monthly check-ins, and injection supplies. A practice billing insurance may carry a higher apparent sticker price but absorb more of the real cost through your premium. The headline number is almost never the full number.
What a Legitimate Evaluation Must Include Before Any Prescription Is Written
A responsible prescriber isn’t making you jump through bureaucratic hoops. Each item in a proper intake has a clinical reason for existing.
You should encounter a complete weight history — not just a single number on the day of your visit, but context about your weight trajectory, previous loss attempts, and how long you’ve been at or above your current weight. This context affects expected response and realistic goal-setting.
Fasting labs are non-negotiable: fasting glucose and HbA1c, a fasting lipid panel, and a comprehensive metabolic panel covering kidney and liver function. GLP-1 agonists can affect kidney function and treat Type 2 diabetes. A prescriber who doesn’t check your baseline glucose before prescribing a drug that lowers blood sugar is flying blind. Labs should be ordered before the prescription is written. The sequence matters.
Blood pressure, taken at the evaluation, matters because these medications interact with cardiovascular risk profiles. Your cardiac and GI history matters equally. The FDA black box warning covers personal or family history of medullary thyroid carcinoma and MEN2. A history of pancreatitis is a relative contraindication. Gastroparesis is a significant concern because GLP-1 agonists slow gastric emptying and can severely worsen that condition. If no one asked about your stomach history, something got skipped.
Your medication list should be reviewed in detail. GLP-1 medications slow gastric emptying, changing how other drugs are absorbed — including insulin. A legitimate prescriber will also explain that titration takes months, that response varies significantly, that some patients see modest results even with full adherence, and that the medication typically must be continued indefinitely because discontinuation leads to regain for most people. If a clinic leads with before-and-after photos and skips that conversation, take note. That’s not an oversight.
Before you leave that first visit, you should have a defined follow-up schedule. Minimum: four weeks after starting, then monthly, with weight check, side effect review, and periodic lab reassessment built in. A clinic that issues a prescription and then offers optional monthly check-ins as an additional fee isn’t providing medical follow-up. It’s upselling.
Red Flags That Signal a Churn-and-Burn Operation
A prescription issued from a web intake form alone — no synchronous video or in-person visit — should stop you cold. Texas telehealth prescribing rules require a valid patient-physician relationship. For non-controlled drugs like semaglutide, the Texas Medical Board’s standard of care still requires enough of an examination to support a clinical judgment. A form asking your height, weight, and whether you have allergies doesn’t constitute that.
No lab work ordered or reviewed before prescribing is a concrete clinical failure. If you ask when labs will be reviewed and the clinic says labs aren’t necessary, leave.
Inability — or unwillingness — to name the compounding pharmacy on the spot is a serious warning sign. You’re injecting this drug into your body. You’re entitled to know where it was made, and a legitimate clinic can answer immediately. They should also be able to tell you whether the pharmacy holds 503A or 503B certification. Evasion here tells you something.
Semaglutide bundled with “skin rejuvenation,” “hydration drips,” or “peptide therapy” packages suggests the prescriber’s primary business is cosmetic commerce, not clinical care. That doesn’t automatically mean incompetent, but their financial incentive is running in a different direction than yours. When physician contact is billed separately as an add-on, the business model is drug dispensing. That’s a meaningful distinction.
The prescriber’s name must appear on your documentation. Every prescription carries a licensed Texas physician’s or APRN’s name and NPI. You can verify any Texas physician’s license at tmb.state.tx.us in under 60 seconds: select “Verification of Licensure,” enter the name, confirm Active status, and check that no disciplinary actions appear. Texas APRNs who prescribe operate under a collaborative prescribing agreement requirement — verify their licensing through the Texas Board of Nursing at bon.texas.gov. Do this. It costs nothing and takes less than a minute.
Compounded Semaglutide in Texas — What’s Legal, What’s Shifting, and What to Ask
The legal basis for compounded semaglutide rests on one specific federal mechanism: the FDA’s drug shortage list. When the FDA declares an approved drug in shortage, federal law permits licensed compounding pharmacies to prepare versions of that drug for patient use. Semaglutide was on that list, and its shortage drove the explosion of compounding operations from 2022 through 2024.
In early 2024, the FDA determined the semaglutide shortage was resolved and removed it from the list. That triggered a legal wind-down period for compounding, with FDA enforcement guidance stating that 503A pharmacies can’t compound copies of commercially available drugs once they’re off the shortage list. As of this writing, enforcement timing remains actively contested. Any clinic claiming the legal status is definitively settled in either direction is oversimplifying — and you should be skeptical of confident answers here.
Texas law does not independently ban compounded semaglutide. The Texas State Board of Pharmacy regulates 503A compounding pharmacies operating in the state. Federal 503B outsourcing facilities operate under FDA oversight and can supply larger quantities to clinics without patient-specific prescriptions. The constraint on compounded semaglutide flows from federal FDA shortage list status, not from a separate Texas prohibition. Tirzepatide occupies a related but distinct legal situation with its own contested status.
Before accepting a compounded GLP-1 prescription, ask three questions. First: Is this FDA-approved or compounded? If compounded, you’re not receiving Wegovy or Ozempic — you’re receiving a pharmacy-prepared version. Second: Which pharmacy produces it? Get the name. You can verify licensing through the Texas State Board of Pharmacy at pharmacy.texas.gov or through the FDA’s 503B outsourcing facility database. Third: Is that pharmacy 503A or 503B licensed? This tells you whether it operates under state oversight as a patient-specific compounder or under FDA oversight as an outsourcing facility.
Compounded semaglutide isn’t inherently unsafe, but quality varies across facilities in ways that FDA-approved drugs don’t. Concentration errors, sterility issues, and variable excipients are documented risks. Asking the pharmacy question isn’t paranoid.
Insurance Reality — What BCBS of Texas, UT SELECT, and Texas Medicaid Actually Cover
“Check with your insurer” helps no one. Here’s what the major Austin-context insurance frameworks actually look like.
GLP-1 coverage for weight loss under BCBS of Texas varies substantially by employer contract. BCBS doesn’t set a single universal GLP-1 policy across all employer clients. Many large-group plans in Austin exclude weight-loss prescribing under a weight management exclusion, even if the same medication would be covered if prescribed for diabetes. Prior authorization for the diabetes indication (Ozempic, Mounjaro) is typically more accessible than for the weight-loss indication (Wegovy, Zepbound). If your employer has a BCBS plan, ask HR for the specific formulary tier and whether a weight management exclusion applies. BCBS general customer service won’t reliably answer this correctly on the first call — the HR benefits contact is the right person.
The University of Texas System employee health plan, UT SELECT, has historically maintained restrictive GLP-1 coverage for weight management. UT System employees should consult the UT SELECT formulary directly rather than assuming coverage based on what a colleague experienced.
Texas Medicaid does not cover GLP-1 medications for obesity treatment. CommUnityCare is the primary FQHC network serving Medicaid patients in Austin. The Texas Medicaid formulary covers semaglutide for Type 2 diabetes management only. Patients who would benefit most from these medications — lower-income patients with obesity-related conditions — face the highest access barriers. CommUnityCare physicians are working within these constraints. The limitation is the payment system, not the practice. That’s worth saying plainly.
ACA marketplace plans present highly variable coverage depending on the specific plan purchased, not just the insurer. Some cover GLP-1 drugs with prior authorization. Others exclude them explicitly.
Novo Nordisk’s WeGoTogether savings card for Wegovy and Eli Lilly’s savings card for Zepbound are explicitly unavailable to patients on Medicare, Medicaid, or other government programs. If you’re uninsured or on a government program, these cards don’t apply to you.
City of Austin employees should call Human Resources Benefits directly rather than relying on coworker accounts. City plan GLP-1 coverage has evolved. An HR benefits specialist can confirm current formulary status in a single conversation.
If You Start at a Med Spa and Want to Switch to a Real Doctor, Here’s What That Costs
This is the transition people don’t think about until they’re already in it.
A med spa operating primarily as a cash-pay dispensing operation typically doesn’t generate or transfer structured medical records. When you arrive at a new physician’s office, they may have no documentation of your starting dose, your titration schedule, side effects you reported, or what labs — if any — were run. You’re starting over.
If you’ve been on compounded semaglutide, a new prescriber must make a fresh prescribing decision, likely with an FDA-approved branded medication. Depending on how far into titration you were, they may restart the titration schedule, adding weeks to reach a therapeutic dose. Any adverse event that occurred during your med spa treatment and wasn’t formally documented is simply gone. If you had significant GI symptoms, elevated heart rate, or anything else worth noting and it wasn’t recorded, a new prescriber can’t factor it into their plan.
Before signing any multi-month package agreement, ask specifically about the refund policy if you discontinue — prorated or not, and whether there’s a no-refund clause after the first visit. Get the answer in writing before paying. This is not a situation where you should take someone’s word for it.
Starting fresh at a legitimate practice means a new evaluation fee — typically $200 to $500 at an obesity medicine specialist, or your specialist copay if insured. You’ll likely face a new prior authorization process under the new prescriber’s name, which starts the insurance clock over. Any coverage you’d satisfied at the med spa, which was cash-pay and not insurance-billed, provides no credit with your insurer.
People make this transition successfully. Know the costs before you’re sunk in them.
Austin Providers Across the Spectrum
What follows is reported to the extent verification was possible; gaps are noted honestly.
UT Health Austin Metabolic Weight Management Program at Dell Seton Medical Center is the most thorough option available in Austin for patients who want specialized obesity medicine care at the medical center level. Intake includes a comprehensive metabolic evaluation, labs, dietary and behavioral assessment, and medication management. The program accepts multiple commercial insurance types and assists with prior authorization. New patient wait times have run several weeks based on reported patient experience. This isn’t the option for someone who wants a prescription by Thursday — but if you have a complex medical history or multiple comorbidities, the wait is probably worth it. Dell Med’s involvement means the clinical bench is deeper than most private practices.
Austin Regional Clinic operates multiple Austin-area sites with primary care physicians who prescribe GLP-1 medications through the standard PCP pathway. That pathway requires comorbidity documentation for insurance prior authorization, which can feel bureaucratic to patients who don’t understand why their doctor needs to document their diabetes before the insurer approves a weight-loss medication. ARC accepts most major commercial insurance. If your PCP is already at ARC, start that conversation there.
CommUnityCare, Austin’s largest FQHC network, operates on a sliding-scale fee structure and serves a substantial Medicaid and uninsured population. CommUnityCare physicians prescribe GLP-1 medications for patients with Type 2 diabetes where formulary coverage applies. For weight management as a primary indication in Medicaid patients, coverage is the binding constraint — not prescriber willingness or clinical judgment. Sites are distributed across East Austin, Del Valle, and other underserved corridors. Patients here aren’t receiving worse clinical thinking. They’re receiving the same clinical thinking inside a more restrictive payment framework.
Independent physicians certified by the American Board of Obesity Medicine have completed additional training in obesity-specific care. ABOM-certified physicians practicing in Austin independently or in small group practices generally provide thorough obesity evaluations and tend to have more flexible scheduling than academic centers. Most accept commercial insurance for the evaluation, though medication coverage depends on your plan.
Several med spas and aesthetics clinics in the Domain area and along South Congress have added GLP-1 prescribing to their service menus. Rather than name specific operations with implied endorsement or condemnation, the more honest framing is this: the prescribing model matters more than the brand name on the door. When we contacted several of these operations during reporting, the quality of information offered on prescriber credentials, compounding pharmacy identity, and follow-up protocols varied substantially. Some were detailed and transparent. Others were evasive — sometimes notably so about basic questions like which pharmacy compounded their product. The TMB license lookup and the three pharmacy questions in the previous section will tell you most of what you need to know about any specific operation.
National telehealth services — Ro, Found, Hims & Hers — connect Austin residents with licensed Texas prescribers via video, satisfying Texas telehealth requirements. Their intake processes vary in rigor; some require labs, some accept self-reported health history. They’re genuinely convenient and, for patients with no significant comorbidities and commercial insurance that covers the medication, can be a reasonable entry point. What they don’t provide: local lab coordination, in-person examination, or a physician who maintains a local chart. If you experience a side effect at 9 p.m. on a Saturday, you’re in a customer service queue. For patients with complex medical histories, that matters.
The Questions to Ask Before You Pay Anything
Take this list to any clinic visit or telehealth intake.
What is the full name and Texas license number of the physician or APRN prescribing to me? Verify the answer at tmb.state.tx.us or bon.texas.gov before your next appointment.
Will you order and review lab work before writing the initial prescription, and what specific labs are included? Minimum acceptable answer: fasting glucose, HbA1c, lipid panel, comprehensive metabolic panel.
Is the medication FDA-approved or a compounded formulation? A direct question that deserves a direct answer.
If compounded — which pharmacy produces it, and is that pharmacy 503A or 503B licensed? You can verify this yourself. A clinic that won’t give you the name has already told you something.
What is your follow-up protocol — how often will I see or speak with a prescriber, what does that include, and is follow-up included in today’s fees? Compare the answer against the standards in the evaluation section above.
What labs will be repeated during treatment, and at what intervals?
If I have significant side effects between appointments, who do I contact and how quickly will someone respond?
If I prepay for a package, what are the specific refund terms if I discontinue? Get this in writing. No exceptions.
If the compounded medication becomes legally unavailable, or if your clinic closes or changes its service model, what happens to my care? A professional will answer this without irritation.
Can you provide documentation of my treatment — doses, titration schedule, labs, reported side effects — so I have a transferable medical record?
A clinic that answers all ten questions directly is demonstrating something. A clinic that stumbles on questions three, four, or nine is demonstrating something too.
CityDesk Austin reporting. Prices and regulatory status were verified to the extent possible at time of publication and are subject to change. Readers should verify current pricing and legal status directly with providers and the relevant regulatory bodies. This is reported journalism, not medical advice.
For more local coverage, explore our Health & Wellness section.
